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Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by accumulation of fat within the Liver. The main objective of this work
is (1) to evaluate the feasibility of measuring in vivo in the liver the shear wave phase velocity dispersion cs(ω) between 20Hz
and 90Hz using vibration-controlled transient elastography (VCTE); (2) to estimate through the rheological Kelvin-Voigt model
the shear elastic μ and shear viscosity η modulus; (3) to correlate the evolution of these viscoelastic parameters on two patients at
Tours Hospital with the hepatic fat percentage measured with T1-weighted gradient-echo in-and out-phase MRI sequence. For the
ﬁrst volunteer who has 2% of fat in the liver, we obtained μ = 1233 ± 133Pa and η = 0.5 ± 0.4Pa.s. For the patient with 22% of
fat, we measure μ = 964± 91Pa and η = 1.77± 0.3Pa.s. In conclusion, this novel method showed to be sensitive in characterizing
the visco-elastic properties of fatty liver.
c© 2015 The Authors. Published by Elsevier B.V.
Peer-review under responsibility of the Scientiﬁc Committee of 2015 ICU Metz.
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1. Motivation
Fatty liver or hepatic steatosis is deﬁned as an excessive accumulation of fat in hepatocytes [?]. On worldwide
grounds, the prevalence of steatosis is very high, and is associated with several factors such as alcohol, diabetes, over-
weight, hyperlipidemia, insulin resistance, hepatitis C genotype 3, abetalipoproteinemia and administration of some
drugs [?]. Non-alcoholic fatty liver disease (NAFLD) is an adaptive response of the liver to insulin resistance. The
natural progression of insulin resistance and endogenous noxious insults (such as free radical production, mitochon-
drial dysfunction, endotoxin) which are related to the presence of excessive fat in the liver, can trigger the development
of non-alcoholic steatohepatitis (NASH). NASH itself can induce a ﬁbrogenic response that can result in cirrhosis [?].
Current guidelines recommend liver biopsy as part of the management of chronic liver disease [?]. This procedure
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provides important information regarding the degree of liver damage, in particular the severity of necroinﬂammatory
activity, ﬁbrosis and steatosis [?]. Unfortunately, liver biopsy has a potential sampling error [?], is invasive, costly and
prone to complications as well . Up to 30% of patients experience pain following the procedure; 0.3% have severe
complications; and mortality approaches 0.01% [?, ?]. As a result of those limitations as well as patient reluctance to
undergo liver biopsy, the estimate of liver injury using non-invasive techniques has gained a growing importance [?,
?]. Shear wave elastography methods where recently applied to steatotic livers. Some studies in phantoms and mouse
livers support the hypothesis that, starting with a normal liver, increasing accumulations of micro- and macrosteatosis
will increase the lossy viscoelastic properties of shear waves in the liver. This results in an increased dispersion (or
slope) of shear wave speed and attenuation in the steatotic liver. Parameters dispersion link to the shear viscosity
provide interesting information on tissue organisation at the microscopic level. A recent paper of ? collect dispersion
studies on normal and steatotic livers using shear wave elastography methods. Four diﬀerent studies at the University
of Rochester (NY-USA) using Crawling wave (Crw) on ex vivo liver, show small variations of the shear wave speed
measured at 200Hz in parallel to an augmentation of the shear phase velocity dispersion with increasing of steatosis.
The large bandwidth [100Hz − 400Hz] for the (Crw) method [?] allows few m/s for the shear celerity dispersion.
These measurements are very encouraging but suﬀer from the limitations of ex vivo experiments: eﬀects of arterial
pressure, body versus room temperature, decomposition over time. This (Crw) method has not been applied in vivo.
Shear Wave Elastography method was adapted for liver examination in vivo by ? on 10 healthy human volunteers in
the [60Hz−390Hz] bandwidth with good reproducibility. Shear celerity dispersion of 0.36m/s/100Hz for healthy vol-
unteers was obtained but no informations was given for the shear viscosity estimation and the steatosis liver pathology
was not addressed.
2. Methods
In this study, we propose to ﬁt the real and imaginary part of the complex strain rate ε˙zz (z, ω) propagation model
in the (z, ω) domain to the experimental data obtained in vivo to estimated robustly the shear wave dispersion. If we
consider an circular extended source located in the plane z = 0 that works in the piston mode and generates a uniform
source force a(0,0,a) over its surface S, the tissue displacement uz (z, t) on the symmetry axis z can be expressed
uz (z, t) = e (t) ⊗ aR
2
ρ0
3
√
z2 + R2
tRectr/cs (t) , (1)
where e(t) is the temporal evolution of the transient vibration, R the radius of the piston, ρ0 the mass density and
cs the shear velocity in a purely elastic media [?]. This expression takes into account the diﬀraction eﬀects of the
shear wave in the very near ﬁeld through the term tRectΔ(t) where RectΔ(t) is a rectangular window of unity height
and duration Δ. The Fourier transform of the expression tRectΔ(t) is calculable analytically. The limit between the
very near ﬁeld and the near ﬁeld of the shear wave occurs at the distance l0 =
√
z20 + R
2 = 3λ4 and if we assume that
l  l0, the particle velocity in the (z, ω) domain can be written as Vz (z, ω) = aR2E(ω)ρ0cs 1z2 e−i
ωz
cs with E(ω) the spectral
bandwidth of the excitation. Applying the correspondence principle [?] we can extend the above solution for linear
elastic solids to include losses. Shear viscosity is introduce through the imaginary part of the wave number k∗ = ωcs −iα
without imposing a particular rheological model [?]. Finally, the particle velocity of the attenuated shear wave in the
viscoelastic liver can be expressed:
Vz (z, ω) =
aR2
ρ0cs (ω)
e−α(ω)z
z2
e−i
ω
cs (ω)
zE (ω) . (2)
During in vivo experiment with (VCTE), we estimate in the liver the shear strain rate ε˙zz (z, ω) = ∂Vz (z, ω)/∂z
on-axis of the vibrator inside the liver. The space derivative of e−ik∗z
/
z2 brings up the terms
(
−ik∗z2 − 2z
)/
z4. If we
neglect the term 2
/
z3 compared to −ik∗
/
z2 and if we assume that the shear wave is not evanescent i.e ω/cs  α to
simpliﬁed the magnitude term, we can get an estimate of the shear strain rate ε˙zz (z, ω) in the near ﬁeld
ε˙zz (z, ω) = −i aR
2ω
ρ0c2s (ω)
e−α(ω)z
z2
e−i
ω
cs (ω)
zE (ω) . (3)
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(a) ε˙zz (z, t) for volunteer 17 (2% fat)
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(b) ε˙zz (z, t) for patient 22 (22% fat)
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(c)eal {ε˙zz (z, ω)} for patient 22.
Fig. 1: in vivo strain rate in the liver in the space/time domain and in the space/frequency domain for volunteer 17 (a) with 2% of fat percent and
patient 22 (b) with %22 of fat percent measured by in and out phase MRI sequence.
This expression of the shear strain rate is the basis of our inverse problem method. The ε˙zz (z, ω) wave have a strong
attenuation by diﬀraction proportional to 1
/
z2, an extra attenuation e−α(ω)z due to viscosity and a classical propagation
term e−ikz. To precisely estimate the attenuation at a speciﬁc frequency ω, we have to robustly compensate the
diﬀraction of the shear wave.
3. Results
We use a Fibroscan research platform for in vivo experiments. Experimental transient strain rate ε˙zz (z, t) is mea-
sured with 0.12mm axial and 0.43ms temporal resolutions respectively using autocorrelation based estimators. Fig.1a
and 1b show the ε˙zz (z, t) elastograms for two patients includes in the clinical study. The ﬁrst patient have 2% of fat and
the second patient have 22% of fat measured with in-out MRI sequence. Fig.1c show the real part of the experimental
strain rate in the (z, ω) domain. For a speciﬁc frequency between [20Hz − 100Hz] a vertical line in Fig.1c describe
the shear wave propagation over z = 3cm to z = 6.5cm. If we suppose that the liver is a homogeneous media, the
shear wavelength λs = cs/ f is clearly visible through the succession of nodes and anti-nodes of the wave. The shear
wavelength decreases with frequency as desired. For a ﬁxed frequency ω0, we use non linear function parameter
estimation for the inverse problem to estimate cs (ω0) and α (ω0) from the analytic expression Eq.(3) and from the
Fourier transform of the experimental ε˙zz (z, t). This estimation parameter procedure is repeated over the bandwidth
of the shear wave [20Hz − 100Hz]. Three successive shear wave speed dispersion measurements of the same patient
are presented on Fig.2a. Dispersion curves in black are for the patient with 2% of fat and curves in red are for the
patient with 22% of fat in the liver. We ﬁnd that around 60Hz, the shear celerity are approximately the same for the
two patient. For this reason a method based on a shear group velocity measurement centred around this frequency will
give the same measurement for the two patients. The dispersion slope in the bandwidth [20Hz : 100Hz] for the patient
with 22% of steatosis is more important (0.5m/s/100Hz) than the dispersion slope for the patient with 2% steatosis.
A Kelvin-Voigt (KV) rheological model ﬁtted to these dispersion curves gives viscoelastic parameters presented in
Table I. Shear elastic modulus μ which is link to the shear celerity at zero frequency in a KV model is lower for the
steatosis patient (μ = 964±91Pa) than for the healthy patient (μ = 1233±133Pa). The shear viscosity is signiﬁcantly
diﬀerent for these two patients and we obtained η = 1.77 ± 0.3Pa.s for patient with 22% of fat and η = 0.5 ± 0.4Pa.s
for the healthy patient.
4. Conclusion
Vibration Controlled Transient Elastography method associate to our novel inverse problem based on an analytical
strain rate propagation model allow us to robustly estimate in vivo the shear wave speed dispersion in the liver. This
method showed to be sensitive in characterizing the visco-elastic properties of fatty liver. A clinical study on 25
steatotic patients with diﬀerent fat percent within the liver is currently underway at Tours hospital.
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(a) Shear wave dispersion in vivo in the human liver.
μ[Pa] η[Pa.s] r2
2% Fat
Measure 1 1512 0.0 0.11
Measure 2 1293 0.5 0.05
Measure 3 1350 0.7 0.01
Median ± IQR 1350±110 0.5±0.4
22% Fat
Measure 1 1080 1.5 0.18
Measure 2 898 1.7 0.59
Measure 3 964 2.2 0.20
Median ± IQR 964±91 1.7±0.3
(b) TABLE I: Viscoelastic parameter measurements.
Fig. 2: Viscoelastic parameter estimation from a KV model for healthy (2% in black) and steatotic (22% fat in red) patient.
